Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyukyu Pharmaceutical is a private Japanese specialty pharmaceutical company focused on formulation innovation, particularly oral thin films and transdermal patches. The company positions itself as a technology-driven pharma manufacturer that develops and commercializes patient-friendly dosage forms, including orally disintegrating films, orally adhesive films, gel patches, and topical tapes. Its business spans manufacturing and sales of ethical drugs and OTC products, with multiple marketed products in pain, inflammation, oral mucosal disease, and itch relief. Kyukyu emphasizes advanced coating, adhesion, and thin-film processing technologies and performs development through factory production internally. The company also appears to collaborate with larger Japanese pharmaceutical companies as a formulation and product development partner.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyu Pharmaceutical.